Newron Pharmaceuticals SpA Cash Flow Reinvestment Rate
Newron Pharmaceuticals SpA cash flow reinvestment rate. Newron Pharmaceuticals SpA (NWRN) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting CHF31.00K (capex CHF31.00K ) from operating cash flow of CHF33.35 Million. Explore NWRN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Newron Pharmaceuticals SpA (2012–2025)
Cash flow reinvestment rate of Newron Pharmaceuticals SpA from 2012 to 2025. Historical reinvestment intensity for Newron Pharmaceuticals SpA across 2 annual periods. Explore Newron Pharmaceuticals SpA capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Newron Pharmaceuticals SpA Cash Flow Reinvestment Rate by Year (2012–2025)
Newron Pharmaceuticals SpA cash flow reinvestment rate by year from 2012 to 2025. Year-by-year capital reinvestment analysis for Newron Pharmaceuticals SpA. For the full cash flow conversion analysis, see NWRN cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CHF13.66 Million | CHF32.56 Million | CHF47.30K | ▲ +22121.3% |
| 2012 | 0.00x | CHF11.00K | CHF5.83 Million | CHF11.00K | — |